Abstract | OBJECTIVE: RESEARCH METHODS: A population of 142 obesity nondiabetic was treated with a hypocaloric diet (1520 kcal) during 3 months. Patients were classified as group I (control, n=112) when serum ( alanine aminotransferase) ALT activity was normal or group II ( NAFLD, n=30) when serum ALT activity was greater than the upper limit of normal reference laboratory (>or=43 UI/L). RESULTS: In control group, body mass index (BMI) (35.3+/-5.6 vs. 33.5+/-5.5: p<0.05), weight (89.6+/-17.2 kg vs. 85.6+/-16.5 kg: p<0.05) and insulin (15+/-7.9 mUI/L vs. 13.1+/-7.4 mUI/L: p<0.05) levels decreased. In NAFLD group, BMI (37.1+/-4.2 vs. 35.1+/-4.6: p<0.05), weight (101+/-22 kg vs. 96.4+/-11.6 kg: p<0.05), insulin (26.8+/-8.9 mUI/L vs. 12.7+/-8.4 mUI/L: p<0.05) and HOMA (3.1+/-1.6 vs. 1.9+/-1.7: p<0.05) decreased. Liver function improved in both groups (ALT; group I 19.9+/-4.6 UI/L vs. 18.3+/-3.9 UI/L: p<0.05 and group II 37.8+/-4.2 UI/L vs. 27.1+/-7.8 UI/L: p<0.05), ( aspartate aminotransferase activity, AST) group I 22.1+/-8.2 UI/L vs. 19.9+/-7.1 UI/L: p<0.05 and group II 73.3+/-11.3 UI/L vs. 38.1+/-11.6UI/L: p<0.05). CONCLUSION:
|
Authors | D A de Luis, R Aller, O Izaola, M Gonzalez Sagrado, R Conde, J M Gonzalez |
Journal | Diabetes research and clinical practice
(Diabetes Res Clin Pract)
Vol. 79
Issue 1
Pg. 74-8
(Jan 2008)
ISSN: 1872-8227 [Electronic] Ireland |
PMID | 17766001
(Publication Type: Journal Article)
|
Chemical References |
- Lipids
- Aspartate Aminotransferases
- Alanine Transaminase
|
Topics |
- Alanine Transaminase
(blood)
- Aspartate Aminotransferases
(blood)
- Blood Pressure
- Body Mass Index
- Body Size
- Diet, Reducing
- Fatty Liver
(blood, diet therapy, enzymology)
- Humans
- Insulin Resistance
(physiology)
- Lipids
(blood)
- Obesity
(diet therapy, enzymology)
|